All I can say is GL - I mean really GL, I hope that you make a mint.
Personally, I think there's a lot of news to come in Sept, but the first interim analysis results worries me a bit. The product works, but it's just the technical definition of what is considered "overwhelming efficacy" that's I'm concerned about
Talking about investing with a lot of conviction and a dash of courage!
You've gone a lot more than just a dash
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-98
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.028(2.44%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.434M | 3.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 326372 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 21814 | 6 |
View Market Depth
| Last trade - 12.41pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |